Skip to Content


Notice of Meeting; Interagency Autism Coordinating Committee

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

The National Institutes of Health (NIH) hereby announces a meeting of the Interagency Autism Coordinating Committee to be held on May 16, 2005, on the NIH campus in Bethesda, Maryland.

The Children's Health Act of 2000 (Pub. L. 106-310), Title I, Section 104, mandated the establishment of an Interagency Autism Coordinating Committee (IACC) to coordinate autism research and other efforts within the Department of Health and Human Services (HHS). In April 2001, the HHS Secretary delegated the authority to establish the IACC to the NIH. Within the NIH, the National Institute of Mental Health (NIMH) is the designated lead for this activity.

The IACC meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person listed below in advance of the meeting.

Name of Committee: Interagency Autism Coordinating Committee.

Date: May 16, 2005.

Time: 9 a.m.-4:30 p.m.

Agenda: Discussion of autism activities across Federal agencies.

Place: National Institutes of Health, 31 Center Drive, Building 31, Conference Room 10 (6th floor), Bethesda, Maryland 20892.

Contact Person: Ann Wagner, PhD, Division of Services and Intervention Research, NIMH, NIH, 6001 Executive Boulevard, Room 7142, MSC 9633, Bethesda, Maryland 20892, E-mail:, Phone: 301-443-4283.

Any member of the public interested in presenting oral comments to the Committee may notify Dr. Wagner, as listed above, at least 5 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Presentations may be limited to 5 minutes; we request both printed and electronic copies for the record. In addition, any interested person may file written comments with the Committee by forwarding his or her statement to Dr. Start Printed Page 10659Wagner, as listed above. The statement should include the name, address, telephone number, and, when applicable, the business or professional affiliation of the interested person.

Information about the meeting and online registration forms are also available on the NIMH homepage at​autismiacc/​index.cfm.

Start Signature

Dated: February 23, 2005.

Raynard S. Kington,

Deputy Director, National Institutes of Health.

End Signature End Preamble

[FR Doc. 05-4171 Filed 3-3-05; 8:45 am]